Cargando…

Virus-Like-Vaccines against HIV

Protection against chronic infections has necessitated the development of ever-more potent vaccination tools. HIV seems to be the most challenging foe, with a remarkable, poorly immunogenic and fragile surface glycoprotein and the ability to overpower the cell immune system. Virus-like-particle (VLP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersson, Anne-Marie C., Schwerdtfeger, Melanie, Holst, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874651/ https://www.ncbi.nlm.nih.gov/pubmed/29439476 http://dx.doi.org/10.3390/vaccines6010010

Ejemplares similares

Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
por: Schwerdtfeger, Melanie, et al.
Publicado: (2019)

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection
por: Zhao, Chongbo, et al.
Publicado: (2016)

Virus‐like particles for vaccination against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus
por: Mazalovska, Milena, et al.
Publicado: (2020)

Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019)

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family
por: Wong, Shu Hui, et al.
Publicado: (2019)

Virus like particle-based vaccines against emerging infectious disease viruses
por: Liu, Jinliang, et al.
Publicado: (2016)

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
por: Gao, Yong, et al.
Publicado: (2018)

Exploiting virus-like particles as innovative vaccines against emerging viral infections
por: Jeong, Hotcherl, et al.
Publicado: (2017)

Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
por: Mogus, Alemu Tekewe, et al.
Publicado: (2020)

Virus-like Particle Vaccines: A Prospective Panacea Against an Avian Influenza Panzootic
por: Ninyio, Nathaniel Nyakaat, et al.
Publicado: (2020)

Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
por: Kim, Chulwoo, et al.
Publicado: (2022)

Harnessing Cellular Immunity for Vaccination against Respiratory Viruses
por: Lukacs, Nicholas W., et al.
Publicado: (2020)

Development of prophylactic vaccines against HIV-1
por: Schiffner, Torben, et al.
Publicado: (2013)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?
por: Yadav, Rashi, et al.
Publicado: (2019)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

Plant-based vaccines against viruses
por: Rybicki, Edward P
Publicado: (2014)

Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)

Virus-Like Particles as an Instrument of Vaccine Production
por: Syomin, B. V., et al.
Publicado: (2019)

Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice
por: Neukirch, Lasse, et al.
Publicado: (2019)

Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus
por: Hashemzadeh, Alireza, et al.
Publicado: (2020)

Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice
por: Andersson, Anne-Marie Carola, et al.
Publicado: (2016)

Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
por: Chen, Chun-Wei, et al.
Publicado: (2020)

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines
por: Fougeroux, Cyrielle, et al.
Publicado: (2017)

No vaccine against HIV yet-are we not perfectly equipped?
por: Singh, Mahender
Publicado: (2006)

Peptide-Based Vaccination for Antibody Responses Against HIV
por: Combadière, Behazine, et al.
Publicado: (2019)

Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
por: Rudometova, N.B., et al.
Publicado: (2022)

Vaccines in Development against West Nile Virus
por: Brandler, Samantha, et al.
Publicado: (2013)

Viral Vector Vaccines against Bluetongue Virus
por: Jiménez-Cabello, Luis, et al.
Publicado: (2020)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

Generation of virus-like particle as a vaccine strategy against bovine leukemia virus
por: Otsuki, Hiroyuki, et al.
Publicado: (2015)

Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials
por: Hompe, Eliza D., et al.
Publicado: (2020)

Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii
por: Lee, Dong Hun, et al.
Publicado: (2016)

Antibody‐virus co‐evolution in HIV infection: paths for HIV vaccine development
por: Bonsignori, Mattia, et al.
Publicado: (2017)

Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses
por: Stromberg, Zachary R., et al.
Publicado: (2020)

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
por: Balke, Ina, et al.
Publicado: (2020)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
por: Go, Hyeon-Jeong, et al.
Publicado: (2021)

Animal and Human Vaccines against West Nile Virus
por: Saiz, Juan-Carlos
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8vj7d869n9dku51ck903vqc0ft